U.S. Renal Data System. USRDS 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011.
National Kidney Foundation. Clinical practice guidelines for vascular access, 2006 update. Am J Kidney Dis 2006; 48(Suppl 1):S176–S285.
Pisoni RL, et al.. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61:305–316.
Mendelssohn DC, Ethier J. Hemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21:721–728.
Moist LM, et al.. Increased hemodialysis catheter use in Canada and associated mortality risk: Data from the Canadian Organ Replacement Registry 2001–2004. Clin J Am Soc Nephrol 2008; 3:1726–1732.
Lok CE, et al.. Trisodium citrate 4%: an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22:477–483.
Moran JE, Ash SR, for the ASDIN Clinical Practice Committee. Locking solutions for hemodialysis catheters; heparin and citrate: A position paper by ASDIN. Semin Dial 2008; 21:490–492.
Besarab A, Pandey R. Catheter management in hemodialysis patients: Delivering adequate flow. Clin J Am Soc Nephrol 2011; 6:227–234.
Janne d’Othée B, Tham JC, Sjeiman RG. Restoration of patency in failing tunneled hemodialysis catheters: A comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping. J Vasc Interv Radiol 2006; 17:1011–1015.
Seddon PA, et al.. Effectiveness of low dose urokinase on dialysis catheter thrombolysis. ASAIO J 1998; 44:M559–M561.
Hemmelgarn BR, et al.. Canadian Hemodialysis Catheter Working Group: Prevention of catheter lumen occlusion with rTPA versus heparin (Pre-CLOT): N Engl J Med 2011; 364:303–312.
Rabindranath KS, et al.. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 2009; 24:3763–3774.
Steczko J, et al.. Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol Dial Transplant 2009; 24:1937–1945.